Consensus Avantor, Inc.

Stocks

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 20:00:02 28/10/2026 GMT			5-day change	1st Jan Change
16.69 ^USD	-2.57%		+3.07%	+49.48%

01:35pm	Avantor, Inc., Q3 2026 Earnings Call, Oct 28, 2026
12:39pm	Avantor's Q3 Adjusted Earnings Flat, Revenue Increases; 2026 Guidance Range Updated	MT

Evolution of the Average Target: Avantor, Inc.

Evolution of the Target Price: Avantor, Inc.

Changes in Analyst Recommendations: Avantor, Inc.

84380a4daa9c08003c7ea.dDjD891up8xggFZhOxPToLXdlxZpiOxFtKHlC5Z6WOU.O3-pt4sv168Ns24nDSDj8cen83cQ65sd8uyrRsQbNbYDaqSRqVnWrRnkOQ~1212d87a85feaa5dfcc4415864f96e81

Analysts' recommendations: Avantor, Inc.

10-09	BofA Securities Adjusts Avantor Price Target to $17 From $14.40	MT
09-09	UBS Adjusts Avantor Price Target to $16 From $10.50, Maintains Neutral Rating	MT
07-30	RBC Raises Price Target on Avantor to $14 From $9, Keeps Sector Perform Rating	MT
07-30	Jefferies Upgrades Avantor to Hold From Underperform, Adjusts Price Target to $13 From $7	MT
07-30	Deutsche Bank Adjusts Avantor Price Target to $13 From $11, Maintains Hold Rating	MT
07-30	The Fed Gets a Better Inflation Number
07-30	Analysts recommendations: Humana, Lam Research, Procter & Gamble, Carvana, Fair Isaac…
07-29	(AVTR) Avantor Expects 2026 Adjusted EPS Range $0.80 to $0.83, vs. FactSet Est of $0.79	MT
07-13	BofA Securities Adjusts Avantor Price Target to $12 From $10	MT
05-15	Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says	MT
02-12	UBS Cuts Avantor Price Target to $10.50 From $13, Maintains Neutral Rating	MT
02-12	Deutsche Bank Cuts Price Target on Avantor to $9 From $12.50, Keeps Hold Rating	MT
12-17	Jefferies Downgrades Avantor to Underperform From Hold, Cuts Price Target to $9 From $12	MT
12-17	Analyst recommendations: Airbnb, Autozone, Constellation Brands, Fortinet, The Gap…
11-04	Raymond James Downgrades Avantor to Market Perform From Outperform	MT
11-04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
30/10/25	Avantor Shares Fall After JPMorgan, Barclays Downgrades	MT
30/10/25	JPMorgan Downgrades Avantor to Neutral From Overweight, Adjusts Price Target to $12 From $14	MT
30/10/25	Barclays Downgrades Avantor to Equalweight From Overweight, Adjusts Price Target to $12 From $15	MT
30/10/25	Analyst recommendations: Boeing, Alphabet, Caterpillar, Chipotle, Wayfair…
20/10/25	BofA Adjusts Price Target on Avantor to $16.50 From $14	MT
03/09/25	RBC Cuts Price Target on Avantor to $16 From $17, Keeps Outperform Rating	MT
04/08/25	Deutsche Bank Trims Avantor Price Target to $14 From $15, Maintains Hold Rating	MT
04/08/25	RBC Cuts Price Target on Avantor to $17 From $20, Keeps Outperform Rating	MT
01/08/25	Jefferies Downgrades Avantor to Hold From Buy, $12 Price Target	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AVANTOR, INC.					-9.52%
	ABBOTT LABORATORIES					+14.96%
	STRYKER CORPORATION					+20.3%
	MEDTRONIC PLC					+11.35%
	ESSILORLUXOTTICA					+18.76%
	CENCORA, INC.					+13.44%
	HOYA CORPORATION					+16.14%
	BECTON, DICKINSON AND COMPANY					+0.28%
	IDEXX LABORATORIES, INC.					+23.73%
	ALCON INC.					+30.6%
	Average					+14.00%
	Weighted average by Cap.					+15.45%